Search Results 1471-1480 of 21306 for Informed consent

  1. PAC203: A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician’s Choice in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post Essential Thrombocythemia Myelofibrosis with Severe Thrombocytopenia (Platelet Counts <50,000/μL) (PACIFICA) - Mayo Clinic

    Provision of informed consent. Exclusion Criteria: Life expectancy <6 months. Completed allogeneic stem cell transplant (allo-SCT) or are eligible for and ...

  2. Mobility Outcomes in Post-Pulmonary Embolic Disease - Mayo Clinic

    Life expectancy <1 year based on comorbidities. Unable/unwilling to provide informed written consent. Note: Other protocol defined Inclusion/Exclusion ...

  3. A Study to Compare the Effects of Liver Preservation for Transplant via Normothermic Machine Perfusion, versus Static Cold Storage - Mayo Clinic

    Subject, or legally authorized representative, is able and willing to give informed consent and HIPAA authorization; Able and willing to comply with all ...

  4. Treatment of Recurrent Clostridium Difficile Infection with RBX7455 - Mayo Clinic

    Willing and able to provide informed consent and HIPAA authorization. Willing and able to complete the required Subject Diary. Willing and able to meet all ...

  5. Expanded Access for LJPC-501 - Clinical Trials

    Patient or legal surrogate is willing and able to provide informed consent per local guidance and patient/legal surrogate is willing to comply with all protocol ...

  6. CraniSeal Post Approval Study - Clinical Trials

    * Patient signs a written Informed Consent form to participate in the study, prior to any study mandated determinations or procedures. * Patients who are ...

  7. A Controlled Clinical Study Of Dupilumab In Patients With Nasal Polyps

    Signed written informed consent. Exclusion Criteria: Patients <18 years of age. Patient who has previously been treated in dupilumab studies. Patient who ...

  8. Testosterone in Treating Postmenopausal Patients with Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment - Mayo Clinic

    Willing to provide informed written consent; Willing to return to an Alliance enrolling institution for follow-up; Willing to provide blood samples for ...

  9. A Study to Assess Peripherally Circulating Plasma Proteins and Clinical Risks to Differentiate Epileptic Seizure from Psychogenic Nonepileptic Seizure - Mayo Clinic

    Able to provide Informed Consent OR are accompanied by a LAR who can provide informed consent on their behalf. Exclusion Criteria - ES and PNES Cohorts: Age ...

  10. A Study Of Advancing Diagnostics For Undiagnosed Diseases Through Multidisciplinary Collaboration - Mayo Clinic

    Able to provide informed consent or has a guardian/legal representative able to provide informed consent. Exclusion Criteria: Individuals with a confirmed ...